# Joan T. Merrill

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/joan-t-merrill/

## Facts

| Field | Value |
| --- | --- |
| Citations | 39,879 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 94 |
| i10-index | 287 |
| Last Known Institution | Oklahoma Medical Research Foundation |
| OpenAlex ID | https://openalex.org/A5052053321 |
| ORCID iD | 0000-0002-4514-2382 |
| Works | 494 |

## Researcher papers

Showing 12 of 23.

- [Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus](https://scholariq.org/papers/derivation-and-validation-of-the-systemic-lupus-international-collaborating/)
- [A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus](https://scholariq.org/papers/a-phase-iii-randomized-placebo-controlled-study-of-belimumab-a-monoclonal/)
- [American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis](https://scholariq.org/papers/american-college-of-rheumatology-guidelines-for-screening-treatment-and/)
- [Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial](https://scholariq.org/papers/efficacy-and-safety-of-rituximab-in-moderately-to-severely-active-systemic-lupus/)
- [Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus](https://scholariq.org/papers/combined-oral-contraceptives-in-women-with-systemic-lupus-erythematosus/)
- [Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis](https://scholariq.org/papers/mycophenolate-mofetil-or-intravenous-cyclophosphamide-for-lupus-nephritis/)
- [Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus](https://scholariq.org/papers/anifrolumab-an-anti-interferon-receptor-monoclonal-antibody-in-moderate-to/)
- [The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial](https://scholariq.org/papers/the-effect-of-combined-estrogen-and-progesterone-hormone-replacement-therapy-on/)
- [The frequency and outcome of lupus nephritis: results from an international inception cohort study](https://scholariq.org/papers/the-frequency-and-outcome-of-lupus-nephritis-results-from-an-international/)
- [A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosus](https://scholariq.org/papers/a-phase-ii-randomized-double-blind-placebo-controlled-dose-ranging-study-of/)
- [Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort](https://scholariq.org/papers/factors-associated-with-damage-accrual-in-patients-with-systemic-lupus/)
- [Predictors of Pregnancy Outcomes in Patients With Lupus](https://scholariq.org/papers/predictors-of-pregnancy-outcomes-in-patients-with-lupus/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Atherosclerosis and Cardiovascular Diseases](https://scholariq.org/topics/atherosclerosis-and-cardiovascular-diseases/)

## Researcher university

- [Oklahoma Medical Research Foundation](https://scholariq.org/institutions/oklahoma-medical-research-foundation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.